LORETELLI, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 1.568
EU - Europa 720
AS - Asia 575
SA - Sud America 162
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.067
Nazione #
US - Stati Uniti d'America 1.541
SG - Singapore 245
BR - Brasile 140
IT - Italia 121
UA - Ucraina 121
CN - Cina 116
SE - Svezia 82
DE - Germania 74
IE - Irlanda 63
TR - Turchia 57
RU - Federazione Russa 54
FI - Finlandia 49
DK - Danimarca 47
VN - Vietnam 43
GB - Regno Unito 40
HK - Hong Kong 38
KR - Corea 25
FR - Francia 23
CI - Costa d'Avorio 19
IN - India 16
MA - Marocco 14
NL - Olanda 14
BE - Belgio 13
MX - Messico 12
CA - Canada 10
BD - Bangladesh 9
IQ - Iraq 7
AR - Argentina 6
EC - Ecuador 6
ID - Indonesia 5
PL - Polonia 5
RS - Serbia 5
ZA - Sudafrica 5
ES - Italia 4
JP - Giappone 4
DO - Repubblica Dominicana 3
VE - Venezuela 3
CO - Colombia 2
CZ - Repubblica Ceca 2
EU - Europa 2
TN - Tunisia 2
UY - Uruguay 2
AT - Austria 1
CL - Cile 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LT - Lituania 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 3.067
Città #
Chandler 193
Singapore 173
Ashburn 166
Jacksonville 128
Fairfield 108
Boardman 63
Ann Arbor 62
Dublin 62
Wilmington 62
Dallas 57
Woodbridge 55
New York 53
Houston 44
Beijing 41
Centro 41
Hong Kong 38
Seattle 38
Cambridge 36
Los Angeles 27
Lawrence 26
Princeton 26
San Mateo 26
Des Moines 22
Abidjan 19
Munich 18
Turin 16
Ho Chi Minh City 15
Turku 15
The Dalles 14
Hanoi 11
Hefei 11
San Diego 11
São Paulo 11
Atlanta 10
Brussels 9
Chicago 9
Helsinki 9
Moscow 9
Chennai 8
Ancona 7
Brasília 6
Buffalo 6
Cagliari 6
Denver 6
London 6
Mexico City 6
Brooklyn 5
Johannesburg 5
Orem 5
San Francisco 5
Santa Clara 5
Amsterdam 4
Belgrade 4
Como 4
Kilburn 4
Montreal 4
Poplar 4
Rio de Janeiro 4
Salt Lake City 4
Stockholm 4
Tokyo 4
Waanrode 4
Warsaw 4
Washington 4
Wuxi 4
Belo Horizonte 3
City of London 3
Curitiba 3
Erbil 3
Fortaleza 3
Guangzhou 3
Izmir 3
Norwalk 3
Phoenix 3
Quito 3
Wuhan 3
Ankara 2
Arzano 2
Baghdad 2
Boston 2
Columbus 2
Frankfurt am Main 2
Guayaquil 2
Indaiatuba 2
Ipatinga 2
Manaus 2
Manchester 2
Montevideo 2
New Bedfont 2
New Delhi 2
Ninh Bình 2
Olomouc 2
Pittsburgh 2
Ponte Nova 2
Porto Alegre 2
Querétaro 2
Rio Grande 2
Roseto degli Abruzzi 2
Salvador 2
Santo André 2
Totale 1.947
Nome #
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 167
An intronic mutation in MLH1 associated with familial colon and breast cancer. 162
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 143
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 138
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 138
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 135
'Secrets and lies'--the difficulties of communicating within families with inherited cancer syndromes. 132
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 128
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 126
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. 124
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment. 123
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 120
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 120
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 113
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 113
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 112
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. 111
MSH2 splice site mutation and endometrial cancer. 110
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 108
Alterazione epigenetica di BRCA1 nei carcinomi mammari 102
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 102
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system 101
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. 99
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 96
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 95
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 95
Totale 3.113
Categoria #
all - tutte 14.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 13 38 38 38 55 43 25
2021/2022215 6 60 2 3 4 11 11 12 13 34 16 43
2022/2023499 30 70 28 42 53 67 0 29 120 4 43 13
2023/2024234 34 4 25 25 39 52 6 8 0 3 5 33
2024/2025476 62 47 12 6 37 8 56 13 96 28 56 55
2025/2026747 112 112 62 199 229 33 0 0 0 0 0 0
Totale 3.113